Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ascorbic Acid | 5 | 2008 | 15 | 0.490 |
Why?
|
| Vasculitis | 2 | 2014 | 5 | 0.490 |
Why?
|
| Protein Disulfide-Isomerases | 2 | 2013 | 4 | 0.480 |
Why?
|
| Macrophage-1 Antigen | 2 | 2014 | 4 | 0.410 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 2 | 0.390 |
Why?
|
| Melanoma, Experimental | 2 | 2007 | 4 | 0.320 |
Why?
|
| Mice | 12 | 2017 | 343 | 0.310 |
Why?
|
| Animals | 13 | 2017 | 1050 | 0.290 |
Why?
|
| Cell Cycle | 1 | 2007 | 3 | 0.270 |
Why?
|
| Neutrophils | 3 | 2014 | 16 | 0.220 |
Why?
|
| Reactive Oxygen Species | 5 | 2007 | 23 | 0.190 |
Why?
|
| Blood Platelets | 2 | 2013 | 17 | 0.180 |
Why?
|
| Interleukin-18 | 3 | 2004 | 6 | 0.150 |
Why?
|
| Apoptosis | 5 | 2007 | 36 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2014 | 67 | 0.140 |
Why?
|
| Humans | 9 | 2017 | 2957 | 0.140 |
Why?
|
| Melanoma | 3 | 2008 | 7 | 0.140 |
Why?
|
| Cell Proliferation | 2 | 2008 | 25 | 0.140 |
Why?
|
| Apolipoproteins | 1 | 2017 | 3 | 0.130 |
Why?
|
| Proteinuria | 1 | 2017 | 3 | 0.130 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2017 | 3 | 0.130 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2017 | 5 | 0.130 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 5 | 0.130 |
Why?
|
| Podocytes | 1 | 2017 | 6 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 6 | 0.130 |
Why?
|
| Male | 4 | 2017 | 1860 | 0.120 |
Why?
|
| Caspases | 3 | 2007 | 11 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2013 | 119 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 10 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2007 | 97 | 0.100 |
Why?
|
| Hemostasis | 1 | 2013 | 2 | 0.100 |
Why?
|
| Thrombosis | 1 | 2013 | 7 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2013 | 4 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2013 | 6 | 0.100 |
Why?
|
| Ligands | 1 | 2013 | 9 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2013 | 8 | 0.100 |
Why?
|
| Protein Binding | 1 | 2013 | 25 | 0.100 |
Why?
|
| Inflammation | 1 | 2013 | 31 | 0.090 |
Why?
|
| Rats | 1 | 2013 | 234 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 3 | 0.080 |
Why?
|
| fas Receptor | 2 | 2007 | 4 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 85 | 0.080 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 15 | 0.070 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2008 | 2 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 9 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2005 | 5 | 0.070 |
Why?
|
| Antioxidants | 2 | 2005 | 17 | 0.070 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2007 | 2 | 0.070 |
Why?
|
| G1 Phase | 1 | 2007 | 4 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 6 | 0.070 |
Why?
|
| Burkitt Lymphoma | 1 | 2007 | 2 | 0.070 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 2 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 4 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 18 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2005 | 22 | 0.070 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2007 | 3 | 0.060 |
Why?
|
| Liver | 1 | 2007 | 6 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 7 | 0.060 |
Why?
|
| Insulin | 1 | 2007 | 9 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2007 | 18 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2008 | 23 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 88 | 0.060 |
Why?
|
| Mitochondria | 2 | 2003 | 12 | 0.060 |
Why?
|
| Receptors, Transferrin | 1 | 2005 | 2 | 0.060 |
Why?
|
| Iron | 1 | 2005 | 5 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2004 | 3 | 0.060 |
Why?
|
| Microglia | 1 | 2004 | 12 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2004 | 3 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 43 | 0.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2004 | 6 | 0.050 |
Why?
|
| RNA, Messenger | 4 | 2007 | 59 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2004 | 11 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 3 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2002 | 2 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2002 | 5 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 7 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2002 | 3 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2011 | 23 | 0.030 |
Why?
|
| Apolipoprotein L1 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 3 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 85 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 65 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 92 | 0.030 |
Why?
|
| Young Adult | 1 | 2017 | 187 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 233 | 0.030 |
Why?
|
| Adolescent | 1 | 2017 | 247 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 14 | 0.030 |
Why?
|
| Pyridines | 2 | 2008 | 12 | 0.030 |
Why?
|
| Imidazoles | 2 | 2008 | 17 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 47 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 18 | 0.030 |
Why?
|
| Middle Aged | 1 | 2017 | 792 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 794 | 0.030 |
Why?
|
| Aged | 1 | 2017 | 956 | 0.030 |
Why?
|
| Talin | 1 | 2014 | 2 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2014 | 3 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cell Communication | 1 | 2014 | 7 | 0.030 |
Why?
|
| Fibrin | 1 | 2013 | 2 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2013 | 3 | 0.020 |
Why?
|
| Shear Strength | 1 | 2013 | 6 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 10 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 28 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 36 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2014 | 76 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2013 | 12 | 0.020 |
Why?
|
| Caspase 8 | 2 | 2003 | 4 | 0.020 |
Why?
|
| Caspase 9 | 2 | 2003 | 4 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 17 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 174 | 0.020 |
Why?
|
| Female | 1 | 2017 | 1724 | 0.020 |
Why?
|
| Calcium | 1 | 2013 | 231 | 0.020 |
Why?
|
| Pseudopodia | 1 | 2011 | 2 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2011 | 2 | 0.020 |
Why?
|
| Microcirculation | 1 | 2011 | 4 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 2011 | 3 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2011 | 21 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 35 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 5 | 0.020 |
Why?
|
| Vitamins | 1 | 2008 | 3 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 22 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2008 | 9 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2007 | 2 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2007 | 2 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2007 | 2 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2005 | 2 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 8 | 0.010 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 2 | 0.010 |
Why?
|
| Titrimetry | 1 | 2004 | 3 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2004 | 4 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2004 | 5 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 6 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 30 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2004 | 6 | 0.010 |
Why?
|
| Densitometry | 1 | 2003 | 2 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2003 | 3 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2003 | 3 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 23 | 0.010 |
Why?
|
| Oxidants | 1 | 2003 | 2 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2003 | 2 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 208 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 97 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2002 | 3 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 21 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 56 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 63 | 0.010 |
Why?
|
| CD48 Antigen | 1 | 2002 | 2 | 0.010 |
Why?
|
| Palatine Tonsil | 1 | 2002 | 2 | 0.010 |
Why?
|
| Trihexosylceramides | 1 | 2002 | 2 | 0.010 |
Why?
|
| Neprilysin | 1 | 2002 | 2 | 0.010 |
Why?
|
| Antigens, CD20 | 1 | 2002 | 2 | 0.010 |
Why?
|
| CD40 Antigens | 1 | 2002 | 2 | 0.010 |
Why?
|
| CD40 Ligand | 1 | 2002 | 2 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2002 | 2 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2002 | 3 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 6 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 16 | 0.010 |
Why?
|